CD8A and neoplasm: Cell surface HSPs are recognized by receptors (such as CD91, LOX1, and CD40) on antigen-presenting cells, which, in turn, mediates the uptake of dying cells and the cross-presentation of tumor antigens to CD8+ T cells.